Clinical Trials Browser

Phase 2 × Completed × ISIS104838 × Clear all

NCT00048321 2022-12-05

ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis

Phase 2 Completed

Arthritis, Rheumatoid